SCHEMBL7344632

SCHEMBL7344632

COc1cc(C)c2[nH]c(Cl)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
ELANE P08246 2/20 0.37
NQO2 P16083 2/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
LMNA P02545 2/20 0.33
HSD17B10 Q99714 1/20 0.33
GFER P55789 1/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR3 P22607 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25648759 0.82 KDM4E (0.45) PDE3BPDE3AELANENQO2ALDH1A1
SCHEMBL7344628 0.72 NUDT1 (0.41) PDE3BPDE3AALDH1A1KDM4ELMNA
SCHEMBL1285923 0.72 KDM4E (0.43) PDE3BPDE3ANQO2ALDH1A1KDM4E
SCHEMBL7341945 0.72 ACHE (0.39) PDE3BPDE3AALDH1A1KDM4EMEN1
SCHEMBL1193199 0.70 ALDH1A1 (0.48) PDE3BPDE3ANQO2ALDH1A1KDM4E
SCHEMBL28391201 0.69 PDE3B (0.37) PDE3BPDE3AALDH1A1KDM4EMEN1
SCHEMBL21642520 0.68 ALDH1A1 (0.41) PDE3BPDE3AELANENQO2ALDH1A1
SCHEMBL7350945 0.68 MMP12 (0.47) ELANEALDH1A1KDM4ELMNAGFER
SCHEMBL25648677 0.68 ALDH1A1 (0.36) PDE3BPDE3AELANENQO2ALDH1A1
SCHEMBL9306577 0.68 ESR2 (0.42) ALDH1A1KDM4ELMNASMN1; SMN2AMY1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed